Advanced search
Publication Cover
Postgraduate Medicine Volume 126, 2014 - Issue 3
Submit an article Journal homepage
30
Views
9
CrossRef citations to date
0
Altmetric
Case Report

A Retrospective Case Series of the Lipid Effects of Switching From Omega-3 Fatty Acid Ethyl Esters to Icosapent Ethyl in Hyperlipidemic Patients

Richard S. Castaldo Niagara Falls Memorial Medical Center, River Road Primary Care Center, North Tonawanda, NYCorrespondence[email protected]
, MD
Pages 268-273 | Published online: 13 Mar 2015

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

James R. Crandell, Christina Tartaglia & Joseph Tartaglia. (2016) Lipid effects of switching from prescription EPA+DHA (omega-3-acid ethyl esters) to prescription EPA only (icosapent ethyl) in dyslipidemic patients. Postgraduate Medicine 128:8, pages 859-864.
Read now
Anurag W. Kedia & Erin Lynch. (2015) Effects of switching from omega-3-acid ethyl esters to icosapent ethyl in a statin-treated patient with elevated triglycerides. Postgraduate Medicine 127:8, pages 869-873.
Read now
Howard S. Weintraub. (2014) Overview of Prescription Omega-3 Fatty Acid Products for Hypertriglyceridemia. Postgraduate Medicine 126:7, pages 7-18.
Read now

Articles from other publishers (6)

Randall P. Sharp, Barry J. Gales & Riaz Sirajuddin. (2017) Comparing the Impact of Prescription Omega-3 Fatty Acid Products on Low-Density Lipoprotein Cholesterol. American Journal of Cardiovascular Drugs 18:2, pages 83-92.
Crossref
Kota J Reddy & Sumita Chowdhury. (2016) Improving lipids with prescription icosapent ethyl after previous use of fish oil dietary supplements. Future Cardiology 12:3, pages 261-268.
Crossref
Richard S. Castaldo. (2016) Switching statin-treated patients from fenofibrate to the prescription omega-3 therapy icosapent ethyl: a retrospective case series. Drugs & Therapy Perspectives 32:4, pages 162-169.
Crossref
Katherine Lyseng-Williamson, Paul L. McCormack & Esther S. Kim. (2016) Icosapent ethyl in hypertriglyceridaemia: a guide to its use. Drugs & Therapy Perspectives 32:3, pages 91-97.
Crossref
James R. Crandell. (2016) Switching from EPA + DHA (Omega-3-acid Ethyl Esters) to High-Purity EPA (Icosapent Ethyl) in a Statin-Treated Patient with Persistent Dyslipidemia and High Cardiovascular Risk: A Case Study. Clinical Medicine Insights: Cardiology 10, pages CMC.S38123.
Crossref
Amir Hassan, Nadeem Tajuddin & Ali Shaikh. (2014) Retrospective Case Series of Patients with Diabetes or Prediabetes Who Were Switched from Omega-3-Acid Ethyl Esters to Icosapent Ethyl. Cardiology and Therapy 4:1, pages 83-93.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.